This spring, more than 120 medical students offered to graduate early and join the frontline of a health care system grappling with a surge of patients during the COVID-19 pandemic. For those who served, their experiences in the clinic provided lasting lessons.
Over the last 25 years, hundreds of clinical trials for drugs treating Alzheimer’s disease have failed. As the field takes stock, a team at IU School of Medicine hunts for new targets—and hope for patients.
Slowing coronavirus requires more than robust testing. It takes a team of contact tracers to connect with people who test positive—one where IU School of Medicine's expertise in global health is crucial.